In its latest Enforcement Report, the US Food and Drug Administration (USFDA) noted that the Mumbai-based drug major is recalling 24,194 pr...

Production of AD immunisation syringes at its plants has fallen from 4.5-5.0 million units per day a year ago to 500,000-600,000 now. "We a...

Rajiv Nath, managing director, HMD, told ET that the government has either suspended the orders or rescheduled it to next year.

In an email dated February 14 to syringe makers, Central Medical Service Society (CMSS)-the government’s procurement body told the manufact...

In 2020-21, the export of syringes stood at USD 45.68 million. It was USD 17.37 million during April-July this fiscal.

The export restrictions on these products were imposed in June last year and August 16, 2021 on account of increasing COVID-19 cases. An ex...

The restriction applies to just three categories of syringes, it said and added that syringes are vital to sustain the momentum of the prog...

Rajiv Nath, President, All India Syringes and Needles Manufacturers Association (AiSNMA) urged the government to lift the restriction on no...

The Directorate General of Foreign Trade (DGFT) said that the export policy for syringes with or without needleshas been amended from “free...

Shortages in vaccine and consumables may not be felt in the first few rounds of inoculations. But they are likely to crop up in the followi...

The Covax facility, which seeks to pool in resources to accelerate the development of the promising vaccine candidates for Covid-19 that wi...

The import price of a popular hip implant is Rs 8,906, but by the time it’s marked on a patient’s bill, it costs Rs 1.29 lakh, a markup of ...

According to WHO, if Safety Cannula is made mandatory in hospitals, then around 80% of all hospital staff can be saved from needle stick in...

"We are looking at entering over 100 countries by the end of 2014 for our formulated PFL syringes," Roselabs Bioscience Director Zameer Aga...

Ahmedabad-based Roselabs Group has set up the first of its kind complete end-to-end pre-filled syringes (PFS) making facility in the world.

Company claims setting up first fully integrated PFS unit and expects to break-even in next two years, as the demand for PFS is rising.

Hindustan Syringes and Medical Devices (HMD) will invest up to Rs 100 crore in the next three years for expansion.